Single point mutations reveal amino acid residues important for Chromobacterium violaceum transaminase activity in the production of unnatural amino acids

被引:0
作者
Sarah A. Almahboub
Tanja Narancic
Darren Fayne
Kevin E. O’Connor
机构
[1] University College Dublin,UCD Earth Institute and School of Biomolecular and Biomedical Science
[2] University College Dublin,BEACON
[3] Trinity Biomedical Sciences Institute, Bioeconomy Research Centre, Ireland
[4] Trinity College Dublin,Molecular Design Group, School of Biochemistry and Immunology
来源
Scientific Reports | / 8卷
关键词
Unnatural Amino Acids (UAAs); Aminotransferase (TA); Transaminasen; F200Y Substitution; Chiral Amines;
D O I
暂无
中图分类号
学科分类号
摘要
Unnatural amino acids (UAAs) are chiral amines with high application potential in drug discovery and synthesis of other valuable chemicals. Biocatalysis offers the possibility to synthesise novel optically pure UAAs with different physical and chemical properties. While the biocatalytic potential of transaminases in the synthesis of UAAs has been demonstrated, there is still a need to improve the activity with non-native substrates and to understand which amino acids residues are important for activity with these UAAs. Using a rational design approach, six variants of Chromobacterium violaceum DSM30191 transaminase (CV_TA) carrying a single and one variant carrying two substitutions were generated. Among the variants with a single substitution, CV_Y168F showed a 2 to 2.6-fold increased affinity for 2-oxooctanoic acid (2-OOA) and 3-oxobutyric acid (3-OBA) methyl ester used to synthesise an α- and β-UAA. Analysis of the first half of the transaminase reaction showed no change in the activity with the donor (S)-1-phenylethylamine. The combination of W60C and Y168F substitutions improved the CV_TA affinity for 2-OOA 10-fold compared to the wild type. Other substitutions showed no change, or reduced activity with the tested substrates. Our findings provide structural information on CV_TA and demonstrate the potential of rational design for biosynthesis of UAAs.
引用
收藏
相关论文
共 97 条
[1]  
Clouthier CM(2012)Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis Chem Soc Rev 41 1585-1605
[2]  
Pelletier JN(2013)Biocatalytic approaches to the synthesis of enantiomerically pure chiral amines Top Catal 57 284-300
[3]  
Ghislieri D(2007)Biocatalysis for pharmaceutical intermediates: the future is now Trends in biotechnology 25 66-73
[4]  
Turner NJ(2013)Design, synthesis, and antiplasmodial activity of hybrid compounds based on ( ACS Med Chem Lett 4 637-641
[5]  
Pollard DJ(2014), Mol Biol Cell 25 2677-2681
[6]  
Woodley JM(2016))-N-benzoyl-3-phenylisoserine J Med Chem 59 10807-10836
[7]  
Njogu PM(2018)How Taxol/paclitaxel kills cancer cells Appl Microbiol Biot 102 789-799
[8]  
Gut J(2012)Unusual amino acids in medicinal chemistry ACS Catal 2 993-1001
[9]  
Rosenthal PJ(2014)Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity Bioorganic & medicinal chemistry letters 24 5349-5356
[10]  
Chibale K(1998)Omega-transaminases for the production of optically pure amines and unnatural amino acids Trends Biotechnol 16 412-418